NCT06460974

Brief Summary

This research was conducted as a randomized controlled study to determine the effect of stress ball application on stress, anxiety and comfort in women with breast cancer receiving chemotherapy.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
74

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2024

Completed
10 days until next milestone

First Submitted

Initial submission to the registry

June 11, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

June 14, 2024

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2024

Completed
Last Updated

June 14, 2024

Status Verified

June 1, 2024

Enrollment Period

6 months

First QC Date

June 11, 2024

Last Update Submit

June 11, 2024

Conditions

Keywords

AnxietyComfortBreast CancerStressStress Ball

Outcome Measures

Primary Outcomes (3)

  • Distress Thermometer

    Distress level is determined by a visual analog scale ranging from "0-10". Patients express the psychological distress they feel with the numbers on the thermometer; "0 points" means that the patient does not experience any distress, and "10 points" means that the patient experiences the highest level of distress

    6 months

  • State-Trait Anxiety Inventory

    It evaluates the state of anxiety felt by the individual due to the stressful situation he is in. The first 20 items, consisting of short statements, measure the individual's state anxiety level.

    6 months

  • General Comfort Scale

    The scale contains a total of 48 items in a four-point Likert type and consists of four sub-dimensions (physical, psycho-spiritual, environmental, and socio-cultural sub-dimensions).

    6 months

Study Arms (2)

stress ball group

EXPERIMENTAL

A stress ball was applied to the patients in the stress ball group during chemotherapy treatment

Other: stress ball

Control group

NO INTERVENTION

Standard care without any additional application

Interventions

A stress ball was applied to the patients in the during chemotherapy treatment.

stress ball group

Eligibility Criteria

Age18 Years - 65 Years
Sexfemale(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • who is literate in Turkish,
  • who was diagnosed with stage 1, 2 and 3 breast cancer
  • who had the second cure or above chemotherapy receiving treatment
  • over 18 years of age
  • female
  • platelet level \>50,000 mm3
  • not having any physical problems squeezing a stress ball

You may not qualify if:

  • those who did not agree to participate in the study
  • those who received chemotherapy for the first time,
  • those who had any physical disability to squeeze a stress ball
  • Any receiving intravenous treatment from both arms,
  • having had a unilateral or bilateral mastectomy and having a problem squeezing a stress ball,
  • having any psychiatric disease,

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mersin University

Mersin, 33110, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Anxiety DisordersBreast Neoplasms

Condition Hierarchy (Ancestors)

Mental DisordersNeoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Birgül VURAL DOĞRU

    Mersin University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Birgül VURAL DOĞRU

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

June 11, 2024

First Posted

June 14, 2024

Study Start

June 1, 2024

Primary Completion

December 1, 2024

Study Completion

December 1, 2024

Last Updated

June 14, 2024

Record last verified: 2024-06

Data Sharing

IPD Sharing
Will not share

Locations